Skip to content

Detection of novel genetic variants within the aquaporins 1 and 5

Detection of novel genetic polymorphisms (single nucleotide polymorphisms [SNPs]) within the aquaporins 1 and 5: an observational single-centre study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN55161632
Enrollment
650
Registered
2009-07-03
Start date
2005-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aquaporines, cell migration and inflammation Respiratory Adult respiratory distress syndrome

Interventions

The following analyses will be performed on each participant: 1. Deoxyribonucleic acid (DNA) extraction from rest material of the routine diagnostic, e.g., saliva, urine or blood 2. Identification of

Sponsors

German Research Council (Deutsche Forschungsgemeinschaft [DFG]) (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Acute respiratory distress syndrome: 1.1. Timing: acute onset 1.2. Oxygenation: partial pressure of oxygen in arterial blood (PaO2)/fraction of inspired oxygen (FiO2) ratio less than 200 mmHg (regardless of positive end expiratory pressure [PEEP]) 1.3. Chest radiograph: bilateral infiltrates seen on frontal chest radiograph 1.4. Pulmonary artery wedge (PAW): less than 18 mmHg when measured or no clinical evidence of left atrial hypertension 2. Lung function testing with body plethysmography-revealed bronchial asthma 3. Patients with severe sepsis 4. Aged 18 to 70 years, both genders

Exclusion criteria

Exclusion criteria: No written informed consent is obtained

Design outcomes

Primary

MeasureTime frame
Detection of SNPs wthin the Aqquaporin 1 and 5 gen which contribute to the phenotypic variability of ARDS, sepsis and bronchial asthma, measured at 30 day survival and 100 day survival

Secondary

MeasureTime frame
Analysis of survival, disease course and rehabilitation, measured at 30 day survival and 100 day survival

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026